These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1621415)

  • 21. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live viral vaccines for respiratory and enteric tract diseases.
    Chanock RM; Murphy BR; Collins PL; Coelingh KV; Olmsted RA; Snyder MH; Spriggs MK; Prince GA; Moss B; Flores J
    Vaccine; 1988 Apr; 6(2):129-33. PubMed ID: 2838984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
    Graham BS; Bunton LA; Wright PF; Karzon DT
    J Clin Invest; 1991 Sep; 88(3):1026-33. PubMed ID: 1909350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice.
    Martinez X; Li X; Kovarik J; Klein M; Lambert PH; Siegrist CA
    Eur J Immunol; 1999 Oct; 29(10):3390-400. PubMed ID: 10540351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children.
    Belshe RB; Anderson EL; Walsh EE
    J Infect Dis; 1993 Oct; 168(4):1024-9. PubMed ID: 8376814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.
    Fleming EH; Ochoa EE; Nichols JE; O'Banion MK; Salkind AR; Roberts NJ
    J Med Virol; 2018 Jan; 90(1):26-33. PubMed ID: 28856681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
    Lee YT; Ko EJ; Kim KH; Hwang HS; Lee Y; Kwon YM; Kim MC; Lee YN; Jung YJ; Kang SM
    J Biomed Nanotechnol; 2017 Jan; 13(1):84-98. PubMed ID: 29302248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model.
    Stack AM; Malley R; Saladino RA; Montana JB; MacDonald KL; Molrine DC
    Vaccine; 2000 Jan; 18(14):1412-8. PubMed ID: 10618539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Lee YN; Hwang HS; Kim MC; Lee YT; Lee JS; Moore ML; Kang SM
    Antiviral Res; 2015 Mar; 115():1-8. PubMed ID: 25513755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective and disease-enhancing immune responses to respiratory syncytial virus.
    Anderson LJ; Heilman CA
    J Infect Dis; 1995 Jan; 171(1):1-7. PubMed ID: 7798649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
    Iqbal M; Lin W; Jabbal-Gill I; Davis SS; Steward MW; Illum L
    Vaccine; 2003 Mar; 21(13-14):1478-85. PubMed ID: 12615444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection, pathogenesis, and therapy of respiratory syncytial virus infections.
    Welliver RC
    Clin Microbiol Rev; 1988 Jan; 1(1):27-39. PubMed ID: 3060243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.
    Connors M; Collins PL; Firestone CY; Sotnikov AV; Waitze A; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1992; 10(7):475-84. PubMed ID: 1609551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses.
    Salkind AR; McCarthy DO; Nichols JE; Domurat FM; Walsh EE; Roberts NJ
    J Infect Dis; 1991 Jan; 163(1):71-7. PubMed ID: 1984478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.
    Schmidt AC; Johnson TR; Openshaw PJ; Braciale TJ; Falsey AR; Anderson LJ; Wertz GW; Groothuis JR; Prince GA; Melero JA; Graham BS
    Virus Res; 2004 Nov; 106(1):1-13. PubMed ID: 15522442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na.
    Goestch L; Plotnicky-Gilquin H; Champion T; Beck A; Haeuw JF; Nguyen T; Bonnefoy JY; Corvaïa N
    Vaccine; 2000 Jun; 18(24):2648-55. PubMed ID: 10781850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.